| scholarly article | Q13442814 |
| P2093 | author name string | B M Bradt | |
| N R Cooper | |||
| C Mold | |||
| G R Nemerow | |||
| P2860 | cites work | Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system | Q24301007 |
| Complement receptor is an inhibitor of the complement cascade | Q24302183 | ||
| Control of the amplification convertase of complement by the plasma protein beta1H | Q24561671 | ||
| Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis | Q24632165 | ||
| Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity | Q24681646 | ||
| Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution | Q24684822 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane | Q28610966 | ||
| Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator | Q28610968 | ||
| Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity | Q28610977 | ||
| Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes | Q28610983 | ||
| Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator | Q28610997 | ||
| Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator | Q28611001 | ||
| Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes | Q34688308 | ||
| Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes | Q36272694 | ||
| Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2 | Q36273277 | ||
| Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes. | Q36346014 | ||
| Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies | Q36346672 | ||
| Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes | Q36347257 | ||
| Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1 | Q36348868 | ||
| Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody | Q36349022 | ||
| Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells | Q36353018 | ||
| Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified protein | Q36863305 | ||
| Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. | Q36887333 | ||
| Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2) | Q36903213 | ||
| Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein | Q36936703 | ||
| Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement | Q36987928 | ||
| Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis | Q36996340 | ||
| Elevated Levels of Antibodies to Epstein-Barr Virus Antigens in Sera and Synovial Fluids of Patients with Rheumatoid Arthritis | Q36997772 | ||
| Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells | Q37014056 | ||
| Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum | Q37546659 | ||
| gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor | Q37679591 | ||
| Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells | Q39392937 | ||
| Membrane complement receptors specific for bound fragments of C3. | Q39614176 | ||
| Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis | Q39920743 | ||
| An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts | Q39979714 | ||
| Human cytomegalovirus: glycoproteins associated with virions and dense bodies | Q40009723 | ||
| Immunodeficiency to the Epstein-Barr virus in the X-linked recessive lymphoproliferative syndrome | Q40117022 | ||
| Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood | Q40122794 | ||
| Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. | Q40170538 | ||
| Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells | Q40171067 | ||
| Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus | Q40295681 | ||
| Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum | Q40830914 | ||
| Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade | Q41367489 | ||
| The role of C4-binding protein and {beta }1H in proteolysis of C4b and C3b | Q41690090 | ||
| Early events in the infection of human B lymphocytes by Epstein-Barr virus: The internalization process | Q41919826 | ||
| Functional and antigenic properties of complement receptor type 2, CR2. | Q42159770 | ||
| Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. | Q42937991 | ||
| Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells | Q43805008 | ||
| Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells | Q44525883 | ||
| Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement | Q44913877 | ||
| Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells | Q45796492 | ||
| Replication of Epstein–Barr virus in human epithelial cells infected in vitro | Q45797458 | ||
| Infection of Normal Human Epithelial Cells by Epstein-Barr Virus | Q45798854 | ||
| Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350. | Q53522133 | ||
| gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4) | Q63380104 | ||
| Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF) | Q67918521 | ||
| Plaque assay of cytomegalovirus strains of human origin | Q68617337 | ||
| Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors | Q70017433 | ||
| Cellular distribution of complement receptor type 4 (CR4): expression on human platelets | Q70017463 | ||
| Antiphagocytic effects of staphylococcal protein A | Q70124474 | ||
| Involvement of human membrane-associated complement components in the rosette formation between marmoset red blood cells and human leukocytes | Q70307183 | ||
| Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus | Q70434953 | ||
| Changes in virulence, M protein and IgG Fc receptor activity in a type 12 group A streptococcal strain during mouse passages | Q71517088 | ||
| Large scale isolation of functionally active components of the human complement system | Q71542480 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 949-969 | |
| P577 | publication date | 1988-09-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Epstein-Barr virus regulates activation and processing of the third component of complement | |
| P478 | volume | 168 |
| Q33734376 | A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells. |
| Q36400453 | A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae |
| Q36231437 | A role for complement receptor-like molecules in iron acquisition by Candida albicans |
| Q36331201 | Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia |
| Q33902027 | Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients |
| Q41188327 | Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells |
| Q36376189 | Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae |
| Q35771684 | Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi |
| Q34061960 | Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri |
| Q36705669 | Complement evasion strategies of microorganisms |
| Q40737570 | Complement-related proteins in pathogenic organisms |
| Q45710613 | Direct Binding of Herpes Simplex Virus Type 1 Virions to Complement C3 |
| Q35216397 | Herpes and pox viral complement control proteins: 'the mask of self'. |
| Q33784923 | Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo |
| Q24675546 | Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41 |
| Q38597254 | Immune Evasion by Epstein-Barr Virus |
| Q36832077 | Immune regulation and evasion of Mammalian host cell immunity during viral infection |
| Q40747557 | In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss |
| Q36375668 | In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC |
| Q28972389 | Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy |
| Q35680172 | Intra-host versus inter-host selection: viral strategies of immune function impairment |
| Q41300802 | Masters of deception: a review of herpesvirus immune evasion strategies |
| Q40641469 | Molecular mimicry. |
| Q34540763 | Neuroinvasion by pathogens: a key role of the complement system |
| Q41329469 | Role of Epstein‐Barr virus and soluble CD21 in persistent polyclonal B‐cell lymphocytosis |
| Q35899072 | Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation |
| Q68860041 | The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46 |
| Q35688515 | The relevance of complement to virus biology |
| Q84522326 | The significance of renal C4d staining in patients with BK viruria, viremia, and nephropathy |
| Q33304402 | The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner |
| Q36791349 | Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence |
| Q35122624 | Viral mimicry of the complement system |
Search more.